Paradromics, a neurotechnology startup, has announced that it has successfully implanted its brain-computer interface (BCI) device into a human for the first time. The company is now preparing to move into the clinical trial phase following this development.
Paradromics’ brain chip was first implanted in a human during a surgery at the University of Michigan on May 14. The patient was already undergoing brain surgery for epilepsy treatment. The company seized this opportunity to temporarily place the device. The chip remained in the brain for approximately 20 minutes and was successfully removed at the end of the procedure.
In a statement released by the company, it was noted that this procedure demonstrated both the safe implantation of the device and its ability to successfully record neural data. Paradromics, founded in 2015, is awaiting regulatory approval to proceed with clinical trials. Following the completion of the approval process, a human trial is planned to examine the long-term safety and effectiveness of the device.
The system developed by Paradromics was introduced under the name “Connexus.” The system aims to enable individuals who have lost the ability to speak due to paralysis to communicate through a computer. The company states that the device can record brain signals at the individual neuron level. Paradromics has received approximately $100 million in investment to date. The company has also announced a strategic collaboration with Saudi Arabia’s NEOM project. Clinical trials are expected to begin within the year.
You Might Also Like;
-
-
-
-
-
-
-
-
-
-
-
-
